Posts With Tag NASDAQ MNPR

Showing 1 - 2 of 2 Posts

Monopar Therapeutics Inc. 8-K Report: Key Updates & Insights for Investors

•

Form 8-K

•

2025-02-24

Last updated: about 1 month ago

Monopar Therapeutics Inc. 8-K Report: Key Updates & Insights for Investors

Explore Monopar Therapeutics Inc.'s 8-K filing from February 19, 2025, revealing crucial updates that impact stakeholders and stock performance. Get the latest on MNPR.

Monopar Therapeutics NASDAQ MNPR 8-K Filing Biotechnology Sector Investor Relations

Monopar Therapeutics Inc. 8-K Report: Key Insights & Updates (Dec 20, 2024)

•

Form 8-K

•

2024-12-23

Last updated: 4 months ago

Monopar Therapeutics Inc. 8-K Report: Key Insights & Updates (Dec 20, 2024)

Discover crucial updates from Monopar Therapeutics Inc. in this 8-K report filed on Dec 20, 2024. Stay informed on significant events impacting MNPR stock.

Monopar Therapeutics biotechnology NASDAQ MNPR 8-K filing financial reporting